DEFINING RACE/ETHNIC BACKGROUND IN STUDIES OF DISPARITIES
|
|
- Shanon Wood
- 5 years ago
- Views:
Transcription
1 NCI Summit on Cancer Disparities: Workshop on Ancestry Informative Markers Panelists and Agenda 3:15-3:40: 3:40: Lisa Newman, MD, MPH: Univ. of Michigan Cancer Disparities and Racial/Ethnic Background: The Need for More Objective Definitions 3:40-4:10: 4:10: Jill Barnholtz-Sloan, PhD: Case-Western Comprehensive Cancer Center Using ancestry estimates as tools to better understand group or individual differences in disease risk/outcomes 4:10-4:30: 4:30: Open Discussion; Question and Answers for Dr. Barnholtz-Sloan 4:30-5:00: Closing Comments and Discussion: Dr. Worta McCaskill-Stevens: Disparities Research and the Minority-Based CCOPs
2 NCI Summit on Cancer Disparities DEFINING RACE/ETHNIC BACKGROUND IN STUDIES OF DISPARITIES Lisa A. Newman, M.D., M.P.H., F.A.C.S. Associate Professor of Surgery Director, Breast Care Center University of Michigan Ann Arbor, MI
3 Cancer Incidence & Mortality, By Race/Ethnicity Prostate Hispanic American Indian/Alaskan Native As ian/pacific Is lander African Am erican White American ************************************************* Lung & Bronchus Hispanic American Indian/Alaskan Native As ian/pacific Is lander African Am erican White American ************************************************* Colon & Rectum Hispanic Mortality Incidence American Indian/Alaskan Native As ian/pacific Is lander African Am erican White American ************************************************* Breast (Female) Hispanic American Indian/Alaskan Native As ian/pacific Is lander African Am erican White American Rate, per 100,000
4 ETIOLOGY OF DISPARITIES IN CANCER OUTCOME Socioeconomic Resources Socioeconomic Resources Socioeconomic Resources Delivery of Care Tumor biology Genetics Lifestyle & Reproductive Experiences Environmental exposures Diet/Nutrition
5 Ethnicity and SES 40% 35% 30% 25% 20% 15% 10% 5% 0% White American African American Am Ind/Alask Nat <Poverty Level Uninsured
6 Cancer Survival and Income/SES
7 Cancer Disparities Are they all the same? Can clinical trial data correct for confounding effects of SES and delivery of care on ethnicityrelated outcome disparities? Unger et al: ASCO Pooled analyses of SWOG adjuvant therapy trials Outcome comparable for all ethnic groups with all cancers except African Americans with hormonallydriven cancers (breast & prostate) Various issues may contribute in different proportions to organ-site-specific cancer disparities
8 BREAST CANCER: A GLOBAL PERSPECTIVE U.S.A Nigeria Ghana France Spain Italy Sweden Hong Kong China Mortality Incidence Argentina Less Developed Countries Developed Countries
9 BREAST CA INCIDENCE & MORTALITY Age-Adjusted Rates (per 100,000 pop n) Mortality Incidence Hispanics Native Amer/Alaskan Nat Asian/Pacific Islander Black White All
10 Breast Cancer Disparities in U.S.A. Outcome disadvantages for African American breast cancer patients are observed for all tumor subtypes, and at all stages of disease
11 IV,>64 100% 80% 60% 40% 20% 0% 100% 80% 60% 40% 20% 0% Chu et al, SEER Data (Cancer, 2003) 6-Year Survival, ER-positive WA AA 6-Year Survival, ER-negative WA AA III,50-64 III,<50 II,>64 II,50-64 II,<50 I,>64 I, IV,50-64 IV,<50 III,>64 I,<50
12 ETHNICITY AND EARLY-STAGE BREAST CANCER SEER Registry, T1 tumors: 1,860 AA and 27,429 WA AA WA ER neg 33.4% 18.4% Node pos 28.8% 21.3% Multivariate mortality hazard ratio for AA pts: 1.29 ( ) Subset analysis of pts with 1 cm tumors Node pos: 17.4% AA vs. 11.7% WA (p<0.0001) Mortality hazard ratio for AA pts 1.15 ( ) Blake et al, ASCO 2003
13 Distribution Group Comedo Status BREAST CANCER DISPARITIES ASCO, 2005 DCIS Outcome, SEER Data Age (5-yr groups) Race Lumpectomy Lumpectomy+RT Non-African American African American Absent p< p= Ipsilateral Breast Cancer Recurrence Hazard Ratio 1.0 p= Present 1.25 p=0.06 Proportional Hazards Model; Baxter et al ASCO, 2005
14 BREAST CANCER IN YOUNG WOMEN: DETROIT SEER DATA, AA and 1,378 W breast cancer pts <40 yrs Feature African American Caucasian P local 42.4% 52.1% Stage regional 45.7% 41.1% distant 7.8% 4.4% Medullary Histology 5.8% 3.3% ER Negative 61.9% 44.4% PR Negative 59.7% 48.8% Newman et al, CANCER, 2002
15 BREAST CANCER IN YOUNG WOMEN: DETROIT SEER DATA, Proportional Hazard of Death*, AA compared to W pts Stage Local Regional Distant Risk Ratio % Confidence Interval *adjusted for age, tumor size, nodal status, ER/PR & histology
16 Breast Cancer Disparities in U.S.A. Survival disadvantages for African American breast cancer patients are observed for all tumor subtypes, and at all stages of disease: Impact of global influences such as disparities in healthcare access and delivery of care
17 SES-Adjusted Meta-Analysis, 2006 >13K AA & 75K WA Breast CA Pts; 19 Studies Bassett Coates Gordon Ansell Neale Eley Perkins Simon (>49 yo) Simon (<50 yo) Franzini Howard Wojcik Yood El Tamer Roetzheim Albain Premen Albain Postmen Polednak Bradley Jatoi Crowe Combined mortality hazard AA Mortality Risk: 1.28 (95% CI ) 1.38) Newman et al JCO 2006
18 ETIOLOGY OF DISPARITIES IN BREAST CANCER OUTCOME Socioeconomic Resources Delivery of Care Tumor biology Genetics Lifestyle & Reproductive Experiences Environmental exposures Diet/Nutrition
19 Breast Cancer Disparities in U.S.A. Increased risk for early onset disease and development of aggressive breast cancer subtypes is observed in women with African ancestry across many variables
20 BREAST CANCER AGE DISTRIBUTION AND RACE-ETHNICITY Among U.S. women younger than 45 yrs, breast cancer incidence higher for AA population Median age at diagnosis 62 years for WA women 57 years for AA women 1/5 of WA pts are younger than 50 years 1/3 of AA breast pts are younger than 50 years
21 Breast Cancer Incidence by ER Status From Anderson et al, Breast Cancer Res and Treat, 2002
22 Disparities in Breast Tumor Biology: ER-Negative Breast Cancer in the U.S. Proportion ER-Negative Breast Cancer 45% 40% 35% 30% 25% 20% 15% 10% 5% 22% 39% 32% 25% 31% 0% White American African American American Indian Asian/Pacific Islander Hispanic/Latina American Li et al; SEER Data, Arch Int Med 2003
23 National Cancer Data Base: Frequency of ER-Neg Tumors by Age, Stage, and Income African American White American Age Category (years) % 41% 29% 35% 26% 17% Stage I 31% 17% II 42% 26% III 47% 32% IV 46% 30% Income <$30,000 37% 23% $30-$45,000 39% 23% $46,000 39% 21%
24 Microarray and Immunohistochemistry to Identify of Breast Tumor Subtypes Carolina Breast Cancer Study: Frequency of triple-negatives by IHC 50% 40% 30% 20% 10% 0% 39% 26% 16% 16% 14% 16% AA All WA All AA Premen WA Postmen AA Postmen WA Postmen Copyright restrictions may apply. Carey, L. A. et al. JAMA 2006;295:
25 ETIOLOGY OF DISPARITIES: HEREDITARY FACTORS? Common features of breast cancer among populations with African ancestry younger age distribution increased prevalence of medullary tumors increased prevalence of ER-neg, aneuploid tumors Increased incidence of male breast cancer
26 Breast Cancer in African American, Sub-Saharan African, and White American Women African :1 African American 2:1 3:1 White American Average Age at Diagnosis (years) Incidence:Mortality Ratio 80% 60% 4% 3% 40% 2% 20% 0% Proportion with Stage III/IV Proportion with High- Grade Tumors Proportion with ER- Negative Tumors 1% 0% Male Breast Cancer
27 Summary Globally, women with African ancestry represent a population that faces a decreased lifetime risk of estrogen receptorpositive breast cancer, and an increased risk for estrogen receptor-negative disease compared to other populations of women Do ethnicity/race-related variations in the oncogenic potential of mammary tissue exist? Exploration of this question requires improved metrics for correlating risk of disease with racial/ethnic ancestry
Adjunct Professor, M.D. Anderson Cancer Center Adjunct Professor, University of Michigan Komen Scholar
Delaware Breast Cancer Coalition 22 nd Annual Breast Cancer Update Genetics and Genomics in Studying Breast Cancer Disparities Related to African Ancestry: Oncologic Anthropology Lisa A. Newman, MD, MPH,
More informationBeyond Flexner 2016: Push for Change
Beyond Flexner 2016: Push for Change African Ancestry and High-Risk/Triple Negative Breast Cancer: From Tuskegee and Race Medicine to Precision Medicine and Oncologic Anthropology Lisa A. Newman, MD, MPH,
More informationHEALTH CARE DISPARITIES. Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center
HEALTH CARE DISPARITIES Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center Goals Understand the epidemiology of breast cancer Understand the broad management of breast cancer
More informationPublic Health Democracy: U.S. and Global Health Disparities in Breast Cancer
Public Health Democracy: U.S. and Global Health Disparities in Breast Cancer Doris Browne, MD, MPH Woodrow Wilson Public Policy Scholar Breast and Gynecologic Cancer Research Group NCI, Division of Cancer
More informationDo Lifestyle or Social Factors Explain Ethnic/Racial Inequalities in Breast Cancer Survival?
Epidemiologic Reviews ª The Author 2009. Published by the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.
More informationSupplementary Online Content
Supplementary Online Content Giannakeas V, Sopik V, Narod SA. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy. JAMA Netw Open. 2018;1(4):e181100.
More informationHealth Disparities Advances in Breast Cancer Treatment. Jo Anne Zujewski April 27, 2009
Health Disparities Advances in Breast Cancer Treatment Jo Anne Zujewski April 27, 2009 Disclaimer Breast Cancer Incidence 1994-2003 Breast Cancer Mortality 1994-2003 Access to Care Comorbidity Biology
More informationGenomic Profiling of Tumors and Loco-Regional Recurrence
1 Genomic Profiling of Tumors and Loco-Regional Recurrence Terry Mamounas, M.D., M.P.H., F.A.C.S. Medical Director, Comprehensive Breast Program UF Health Cancer Center at Orlando Health Professor of Surgery,
More informationRacial/Ethnic Disparities in Second Breast Lesions after DCIS. Graham A. Colditz, MD DrPH Kevin Garza Ying Liu, MD PhD Rosy Luo, PhD Yu Tao, PhD
Racial/Ethnic Disparities in Second Breast Lesions after DCIS Graham A. Colditz, MD DrPH Kevin Garza Ying Liu, MD PhD Rosy Luo, PhD Yu Tao, PhD Why DCIS? DCIS over 45,000 cases per year SEER 18 Cancer
More informationBreast Cancer Subtypes Defined by HR/HER2 among Black Cases in the US by Birthplace
NAACCR 2018 Annual Conference Breast Cancer Subtypes Defined by HR/HER2 among Black Cases in the US by Birthplace Hyuna Sung, PhD; Carol Desantis, MPH; Stacey Fedawa, PhD; Ahmedin Jemal, DVM, PhD Surveillance
More informationBreast Cancer Treatment, Outcomes and Recent Advances. Ogori N Kalu, MD, MS Director Breast Surgery-UH Asst. Prof of Surgery Rutgers NJ Med School
Breast Cancer Treatment, Outcomes and Recent Advances Ogori N Kalu, MD, MS Director Breast Surgery-UH Asst. Prof of Surgery Rutgers NJ Med School National Statistics 1 in 8 women in the U.S. (12-13%) will
More informationHealth Inequity and Controversies in Cancer Screening. Doris Browne, MD, MPH Immediate Past President, NMA September
Health Inequity and Controversies in Cancer Screening Doris Browne, MD, MPH Immediate Past President, NMA September 12 2018 DISCLOSURE In compliance with ACCME Guidelines, I hereby declare: I do not have
More informationElisa V. Bandera, MD, PhD
Elisa V. Bandera, MD, PhD Associate Professor of Epidemiology Rutgers Cancer Institute of New Jersey Rutgers School of Public Health American Institute for Cancer Research Annual Conference on Food, Nutrition,
More informationWhat is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people*
What is the Impact of Cancer on African Americans in Indiana? Table 13. Burden of Cancer among African Americans Indiana, 2008 2012 Average number of cases per year Rate per 100,000 people* Number of cases
More informationCurrent Status of Accelerated Partial Breast Irradiation. Julia White MD Professor, Radiation Oncology
Current Status of Accelerated Partial Breast Irradiation Julia White MD Professor, Radiation Oncology I have no disclosures relative to the presented material Agenda ABPI Timeline APBI by Method Clinical
More informationWhat It Takes to Get Incorporation Into Guidelines and Reimbursement for Advanced Cancer Diagnostics: Lessons from Oncotype DX
What It Takes to Get Incorporation Into Guidelines and Reimbursement for Advanced Cancer Diagnostics: Lessons from Oncotype DX WSMOS Meeting Oct 2013 Steven Shak, MD Genomic Health Disclosure: October
More informationUnderstanding and Optimizing Treatment of Triple Negative Breast Cancer
Understanding and Optimizing Treatment of Triple Negative Breast Cancer Edith Peterson Mitchell, MD, FACP Clinical Professor of Medicine and Medical Oncology Program Leader, Gastrointestinal Oncology Department
More informationNational Landmark Reports Highlighting Cancer Disparities Problem
National Landmark Reports Highlighting Cancer Disparities Problem Pre - 1980 1986 1989 1996 1999 2001 2002 2003 5 Leading Causes of Death, U.S., 2003, Female 1 2 3 4 5 All races Cardiovascular Cancer Cerebrovascular
More informationAdvancing Health Equity in Lung Cancer Outcomes
Advancing Health Equity in Lung Cancer Outcomes Edwin J Jackson Jr. DO Pulmonary and Critical Care Medicine Disclosures Funding: American Thoracic Society 2 1 Lecture Outline Cancer Disparities Smoking
More informationSurvival among Native American Adolescent and Young Adult Cancer Patients in California
Survival among Native American Adolescent and Young Adult Cancer Patients in California Cyllene R. Morris, 1 Yi W. Chen, 1 Arti Parikh-Patel, 1 Kenneth W. Kizer, 1 Theresa H. Keegan 2 1 California Cancer
More informationBreast Cancer. Dr. Andres Wiernik 2017
Breast Cancer Dr. Andres Wiernik 2017 Agenda: The Facts! (Epidemiology/Risk Factors) Biological Classification/Phenotypes of Breast Cancer Treatment approach Local Systemic Agenda: The Facts! (Epidemiology/Risk
More informationThe effect of delayed adjuvant chemotherapy on relapse of triplenegative
Original Article The effect of delayed adjuvant chemotherapy on relapse of triplenegative breast cancer Shuang Li 1#, Ding Ma 2#, Hao-Hong Shi 3#, Ke-Da Yu 2, Qiang Zhang 1 1 Department of Breast Surgery,
More informationAssessment of Risk Recurrence: Adjuvant Online, OncotypeDx & Mammaprint
Assessment of Risk Recurrence: Adjuvant Online, OncotypeDx & Mammaprint William J. Gradishar, MD Professor of Medicine Robert H. Lurie Comprehensive Cancer Center of Northwestern University Classical
More informationBreast Cancer Risk and Disease Outcomes for Australian Aboriginal Women
Breast Cancer Risk and Disease Outcomes for Australian Aboriginal Women On the Agenda How frequent is breast cancer in the Indigenous population relative to non- Indigenous people. How do breast cancer
More informationCharacteristics of Philadelphia Census Tracts with High Prostate Cancer Risk
Characteristics of Philadelphia Census Tracts with High Prostate Cancer Risk Charnita Zeigler-Johnson, PhD, MPH Thomas Jefferson University Philadelphia, PA Using Cancer Registry Data in Disparities Research
More informationResults of the ACOSOG Z0011 Trial
DCIS and Early Breast Cancer Symposium JUNE 15-17 2012 CAPPADOCIA Results of the ACOSOG Z0011 Trial Kelly K. Hunt, M.D. Professor of Surgery Axillary Node Dissection Staging, Regional control, Survival
More informationAlthough African American women have a lower incidence of. Histologic Grade, Stage, and Survival in Breast Carcinoma
908 Histologic Grade, Stage, and Survival in Breast Carcinoma Comparison of African American and Caucasian Women Donald Earl Henson, M.D. 1 Kenneth C. Chu, Ph.D. 2 Paul H. Levine, M.D. 3 1 Department of
More informationBreast cancer staging update. Ekaterini Tsiapali, MD, FACS MedStar Regional Breast Program Site Director
Breast cancer staging update Ekaterini Tsiapali, MD, FACS MedStar Regional Breast Program Site Director 1 1 Review of the AJCC 8 th edition breast cancer staging Review of genomic assays as stage modifiers
More informationEvaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials
Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials Mary Beth Terry, PhD Department of Epidemiology Mailman School of Public Health Racial and Ethnic Disparities in
More informationPRINCIPLES FOR ELIMINATING DISPARITIES THROUGH HEALTH CARE REFORM. John Z. Ayanian, MD, MPP
PRINCIPLES FOR ELIMINATING DISPARITIES THROUGH HEALTH CARE REFORM John Z. Ayanian, MD, MPP Harvard Medical School Brigham and Women s Hospital Harvard School of Public Health 8 th Annual National Summit
More informationScarlett Gomez, MPH, PhD Cancer Prevention Institute of California NAACCR 2017 conference, Albuquerque NM June 2017
The influence of socioeconomic status and ethnic enclave on endometrial cancer mortality among Hispanic and Asian American/Pacific Islander women in California Scarlett Gomez, MPH, PhD Cancer Prevention
More informationUnique Aspects of Breast Cancer in African American Women: TRIPLE NEGATIVE BREAST CANCER
Angel A. Rodriguez, M.D. Assistant Professor Weill Cornell Medical College Methodist Cancer Center January 26, 2013 Unique Aspects of Breast Cancer in African American Women: TRIPLE NEGATIVE BREAST CANCER
More informationImpact of Poor Healthcare Services
Competency 3 Impact of Poor Healthcare Services Updated June 2014 Presented by: Lewis Foxhall, MD VP for Health Policy Professor, Clinical Cancer Prevention UT MD Anderson Cancer Center Competency 3 Objectives
More informationTheresa Keegan, Ph.D., M.S. Associate Professor Department of Internal Medicine Division of Hematology and Oncology
Impact of treatment and insurance on socioeconomic disparities in survival after adolescent and young adult Hodgkin lymphoma: A population- based study Theresa Keegan, Ph.D., M.S. Associate Professor Department
More informationORIGINAL ARTICLE BREAST ONCOLOGY. Ann Surg Oncol DOI /s z
Ann Surg Oncol DOI 10.1245/s10434-016-5420-z ORIGINAL ARTICLE BREAST ONCOLOGY Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients:
More informationBreast Cancer in Women from Different Racial/Ethnic Groups
Cornell University Program on Breast Cancer and Environmental Risk Factors in New York State (BCERF) April 2003 Breast Cancer in Women from Different Racial/Ethnic Groups Women of different racial/ethnic
More informationCancer of the Breast (Female) - Cancer Stat Facts
Page 1 of 9 Home Statistical Summaries Cancer Stat Facts Cancer of the Breast (Female) Cancer Stat Facts: Female Breast Cancer Statistics at a Glance At a Glance Estimated New Cases in 2016 % of All New
More informationDisparities in Progress against Cancer in the USA
Disparities in Progress against Cancer in the USA Ahmedin Jemal, DVM, PhD American Cancer Society ASPO Webinar November 29, 2018 Progress in reducing cancer death rates in the US, 1970-2015 240 220 215
More informationA Population-Based Study From the California Cancer Registry. BACKGROUND. Tumor markers are becoming increasingly important in breast cancer
1721 Descriptive Analysis of Estrogen Receptor (ER)- Negative, Progesterone Receptor (PR)-Negative, and HER2-Negative Invasive Breast Cancer, the So-called Triple-Negative Phenotype A Population-Based
More informationBurden of Cancer in California
Burden of Cancer in California California Cancer Reporting and Epidemiologic Surveillance Institute for Population Health Improvement UC Davis Health August 22, 2018 Outline 1. Incidence and Mortality
More informationData Issues in Studying Small Populations Challenges, Opportunities, and a Case Study
Data Issues in Studying Small Populations Challenges, Opportunities, and a Case Study Scarlett Lin Gomez, MPH, PhD Department of Epidemiology & Biostatistics, University of California, San Francisco A
More informationDisparities in Transplantation Caution: Life is not fair.
Disparities in Transplantation Caution: Life is not fair. Tuesday October 30 th 2018 Caroline Rochon, MD, FACS Surgical Director, Kidney Transplant Program Hartford Hospital, Connecticut Outline Differences
More informationBREAST CANCER IN TARRANT COUNTY: Screening, Incidence, Mortality, and Stage at Diagnosis
NIMHD* CENTER OF EXCELLENCE: COMMUNITY OUTREACH CORE* BREAST CANCER IN TARRANT COUNTY: Screening, Incidence, Mortality, and Stage at Diagnosis Updated January 2014 *Supported by the National Institute
More informationRadiotherapy Management of Breast Cancer Treated with Neoadjuvant Chemotherapy. Julia White MD Professor, Radiation Oncology
Radiotherapy Management of Breast Cancer Treated with Neoadjuvant Chemotherapy Julia White MD Professor, Radiation Oncology Agenda Efficacy of radiotherapy in the management of breast cancer in the Adjuvant
More informationIdentifying Geographic & Socioeconomic Disparities in Access to Care for Pediatric Cancer Patients in Texas
Identifying Geographic & Socioeconomic Disparities in Access to Care for Pediatric Cancer Patients in Texas Mary T. Austin, MD, MPH Assistant Professor, Pediatric Surgery University of Texas Health Science
More informationAgenda CIAHD Monthly Research Meeting SPH Tower 1, Room 4645 February 3, :30 3:00pm. I. Meeting Overview 5 minutes
Agenda CIAHD Monthly Research Meeting SPH Tower 1, Room 4645 February 3, 2010 1:30 3:00pm I. Meeting Overview 5 minutes II. Project Presentations 2008/2009 Funded Pilot Project: PI Marc Turenne Disparities
More informationCancer Health Disparities in Tarrant County
Cancer Health Disparities in Tarrant County A presentation to the Tarrant County Cancer Disparities Coalition May 3, 07 Marcela Gutierrez, LMSW Assistant Professor in Practice UTA School of Social Work
More information6/20/2012. Co-authors. Background. Sociodemographic Predictors of Non-Receipt of Guidelines-Concordant Chemotherapy. Age 70 Years
Sociodemographic Predictors of Non-Receipt of Guidelines-Concordant Chemotherapy - among Locoregional Breast Cancer Patients Under Age 70 Years Xiao-Cheng Wu, MD, MPH 2012 NAACCR Annual Conference June
More informationGender Disparities in Viral Suppression and Antiretroviral Therapy Use by Racial and Ethnic Group Medical Monitoring Project,
Gender Disparities in Viral Suppression and Antiretroviral Therapy Use by Racial and Ethnic Group Medical Monitoring Project, 2009-2010 Linda Beer PhD, Christine L Mattson PhD, William Rodney Short MD,
More informationOncology Clinical Research & Race: Statistical Principles
Oncology Clinical Research & Race: Statistical Principles Daniel Sargent, PhD ALLIANCE Group Statistician November 2014 The Literary Digest predicted Alf Landon would win the presidency in 1936 1936 PRESIDENTIAL
More informationTable of Contents. 2 P age. Susan G. Komen
RHODE ISLAND Table of Contents Table of Contents... 2 Introduction... 3 About... 3 Susan G. Komen Affiliate Network... 3 Purpose of the State Community Profile Report... 4 Quantitative Data: Measuring
More informationNeoadjuvant Treatment of. of Radiotherapy
Neoadjuvant Treatment of Breast Cancer: Role of Radiotherapy Neoadjuvant Chemotherapy Many new questions for radiation oncology? lack of path stage to guide indications should treatment response affect
More informationCancer Care Delivery and Research Capacity
Cancer Care Delivery and Research Capacity Olufunmilayo I Olopade, MD ACS Clinical Research Professor Director, Center for Global Health The University of Chicago NCPF Workshop Nov 2016 Overview Introduction
More informationBreast cancer presents a major risk to American. Cancer recurrence and survival in patients with early-stage triple-negative breast cancer
Original Research Cancer recurrence and survival in patients with early-stage triple-negative breast cancer Neal P. Christiansen, MD, 1 Lei Chen, MD, PhD, 2 James Gilmore, DPharm, 3 and Stephen Szabo,
More informationCANCER SCREENING IN MINORITY AND UNDERSERVED POPULATIONS
CANCER SCREENING IN MINORITY AND UNDERSERVED POPULATIONS Gina Villani, MD, MPH CEO and Medical Director Healthfirst 2016 Fall Symposium Prevention as a Priority in Value-Based Healthcare Part II Disparities
More informationChapter 5: Epidemiology of MBC Challenges with Population-Based Statistics
Chapter 5: Epidemiology of MBC Challenges with Population-Based Statistics Musa Mayer 1 1 AdvancedBC.org, Abstract To advocate most effectively for a population of patients, they must be accurately described
More informationCervical Cancer Screening and Prevention in Latinas. Sandra Torrente, MD, MSc Kenneth Grullon, MD
ç Cervical Cancer Screening and Prevention in Latinas Sandra Torrente, MD, MSc Kenneth Grullon, MD Objectives Cervical cancer epidemiology Cervical cancer screening rates locally Health Disparities of
More informationNorthampton County State of the County Health Report (SOTCH)
Northampton County 2017 State of the County Health Report (SOTCH) Northampton County Health Department 9495 NC Highway 305 P.O. Box 635 Jackson, NC 27845 (252)534-5841 Andy Smith, Health Director Virginia
More informationSpeaker s Bureau. Travel expenses. Advisory Boards. Stock. Genentech Invuity Medtronic Pacira. Faxitron. Dune TransMed7 Genomic Health.
Management of DCIS Shawna C. Willey, MD, FACS Professor of Surgery, Georgetown University Director, Medstar Regional Breast Health Program Chief, Department of Surgery Medstar Georgetown University Hospital
More informationSurgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database
Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database Hadi Khan, MD 1, Adam J. Olszewski, MD 2 and Ponnandai S. Somasundar, MD 1 1 Department
More informationThe Differential Health of Women and Minorities
The Differential Health of Women and Minorities CHS 150, November, 6, 2013 Marjorie Kagawa Singer, PhD, MA,MN,RN, FAAN UCLA Fielding School of Public Health and Asian American Studies Minority Non-Minority
More information2017 Topics. Biology of Breast Cancer. Omission of RT in older women with low-risk features
2017 Topics Biology of Breast Cancer Early-stage HER2+ breast cancer-can we avoid RT? Prediction tools for locoregional recurrence Omission of RT in older women with low-risk features Local-Regional Recurrence
More informationFinancial Disclosure. Learning Objectives. Use of Genomics in the NCDB, Early Data Analysis. I have no financial disclosures
Use of Genomics in the NCDB, Early Data Analysis Katharine Yao, MD Chief, Division of Surgical Oncology NorthShore University HealthSystem Chair, QI Committee, NAPBC Financial Disclosure I have no financial
More informationSFMC Breast Cancer Site Study: 2011
SFMC Breast Cancer Site Study: 2011 Introduction Breast cancer is the most frequently diagnosed cancer among American women, except for skin cancers. It is the second leading cause of cancer death in women,
More informationChanging Patient Base. A Knowledge to Practice Program
Changing Patient Base A Knowledge to Practice Program Learning Objectives By the end of this tutorial, you will: Understand how demographics are changing among patient populations Be aware of the resulting
More informationDIAGNOSTICS ASSESSMENT PROGRAMME
DIAGNOSTICS ASSESSMENT PROGRAMME Evidence overview Tumour profiling tests to guide adjuvant chemotherapy decisions in people with breast cancer (update of DG10) This overview summarises the key issues
More informationCommunities and Universities Working Together to Reduce Cancer Disparities Symposium 2005 UCLA
Communities and Universities Working Together to Reduce Cancer Disparities Symposium 2005 UCLA Marjorie Kagawa Singer, Ph.D., M.N., M.A., R.N. UCLA School of Public Health and Asian American Studies Center
More informationBy: Alexia Achu, Catherine Phamduy, & Yen Phan 1
By: Alexia Achu, Catherine Phamduy, & Yen Phan 1 Female Breast Composition Lobules: milk producing glands Female Breast Anatomy Ducts: ducts that carry the milk from the lobules to the nipple Stroma: fatty
More information11th Annual Population Health Colloquium. Stan Skrzypczak, MS, MBA Sr. Director, Marketing Genomic Health, Inc. March 15, 2011
11th Annual Population Health Colloquium Stan Skrzypczak, MS, MBA Sr. Director, Marketing Genomic Health, Inc. March 15, 2011 Agenda Personalized medicine in oncology healthcare Clinical relevance of personalized
More informationRacial and Ethnic Disparities in the Impact of Obesity on Breast Cancer Risk and Survival: A Global Perspective 1 3
REVIEW Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer and Survival: A Global Perspective 1 3 Elisa V Bandera, 4,5 * Gertraud Maskarinec, 6 Isabelle Romieu, 7 and Esther M John
More informationCanada: Equitable Cancer Care Access and Outcomes? Historic Observational Evidence: Incidence Versus Survival, Canada Versus the United States
Canada: Equitable Cancer Care Access and Outcomes? Historic Observational Evidence: Incidence Versus Survival, Canada Versus the United States This work is funded by the: Canadian Institutes of Health
More informationPercent Surviving 5 Years 89.4%
Page 1 of 8 Surveillance, Epidemiology, and End Results Program Turning Cancer Data Into Discovery Home Statistical Summaries Cancer Stat Fact Sheets Cancer of the Breast SEER Stat Fact Sheets: Breast
More informationPrinciples of breast radiation therapy
ANZ 1601/BIG 16-02 EXPERT ESMO Preceptorship Program 2017 Principles of breast radiation therapy Boon H Chua Professor Director of Cancer and Haematology Services UNSW Sydney and Prince of Wales Hospital
More informationBREAST CONSERVATION TREATMENT IN EARLY STAGE DISEASE AND DCIS LAWRENCE J. SOLIN, MD, FACR, FASTRO
BREAST CONSERVATION TREATMENT IN EARLY STAGE DISEASE AND DCIS LAWRENCE J. SOLIN, MD, FACR, FASTRO Chairman Department of Radiation Oncology Albert Einstein Medical Center Philadelphia, PA Professor (Adjunct)
More informationCase 1. BREAST CANCER From Diagnosis to Treatment: The Role of Primary Care
BREAST CANCER From Diagnosis to Treatment: The Role of Primary Care Leah Karliner, MD MAS University of California San Francisco Primary Care Medicine Update 2009 April 2009 Case 1 AR, a 60 year old African
More informationSurgical treatment of BRCA mutated patients. Viviana Galimberti MD European Institute of Oncology Milan, Italy
Surgical treatment of BRCA mutated patients Viviana Galimberti MD European Institute of Oncology Milan, Italy No pharmaceutical company funding was used I declare I have no conflicts of interest as regards
More informationTable of Contents. 2 P age. Susan G. Komen
NEVADA Table of Contents Table of Contents... 2 Introduction... 3 About... 3 Susan G. Komen Affiliate Network... 3 Purpose of the State Community Profile Report... 4 Quantitative Data: Measuring Breast
More informationSENTINEL LYMPH NODE BIOPSY FOR PATIENTS WITH EARLY-STAGE BREAST CANCER
SENTINEL LYMPH NODE BIOPSY FOR PATIENTS WITH EARLY-STAGE BREAST CANCER Clinical Practice Guideline Update Introduction The original ASCO evidence-based clinical practice guidelines on use of sentinel node
More informationTable of Contents. 2 P a g e. Susan G. Komen
NEW HAMPSHIRE Table of Contents Table of Contents... 2 Introduction... 3 About... 3 Susan G. Komen Affiliate Network... 3 Purpose of the State Community Profile Report... 4 Quantitative Data: Measuring
More informationRacial and Socioeconomic Disparities in Appendicitis
Racial and Socioeconomic Disparities in Appendicitis Steven L. Lee, MD Chief of Pediatric Surgery, Harbor-UCLA Associate Clinical Professor of Surgery and Pediatrics David Geffen School of Medicine at
More informationPublic Health. W a k e C o u n t y H u m a n S e r v i c e s P u b l i c H e a l t h Q u a r t e r l y R e p o r t. Prevent. Promote.
Public Health W a k e C o u n t y H u m a n S e r v i c e s P u b l i c H e a l t h Q u a r t e r l y R e p o r t J u l y D e c e m b e r 2 0 1 3 Prevent S p e c i a l E d i t i o n : C a n c e r, H e
More informationPopulations of Color in Minnesota
Populations of Color in Minnesota Health Status Report Update Summary Fall 2002 Center for Health Statistics Minnesota Department of Health Table of Contents Part I: Birth Related Indicators...1 Low Birthweight...1
More informationConsiderations in Adjuvant Chemotherapy. Joyce O Shaughnessy, MD Baylor Sammons Cancer Center Texas Oncology US Oncology
Considerations in Adjuvant Chemotherapy Joyce O Shaughnessy, MD Baylor Sammons Cancer Center Texas Oncology US Oncology 80 70 60 50 40 30 20 10 0 EBCTCG 2005/6 Overview Control Arms with No Systemic Treatment
More informationBreast Cancer Statistics, 2017, Racial Disparity in Mortality by State
CA CANCER J CLIN 2017;67:439 448 Breast Cancer Statistics, 2017, Racial Disparity in Mortality by State Carol E. DeSantis, MPH 1 ; Jiemin Ma, PhD 2 ; Ann Goding Sauer, MSPH 3 ; Lisa A. Newman, MD, MPH
More informationUsing claims data to investigate RT use at the end of life. B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center
Using claims data to investigate RT use at the end of life B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center Background 25% of Medicare budget spent on the last year of life.
More informationADVANCED BREAST CANCER. Polly Niravath, MD Baylor College of Medicine Lester & Sue Smith Breast Center
ADVANCED BREAST CANCER Polly Niravath, MD Baylor College of Medicine Lester & Sue Smith Breast Center AGENDA What is Advanced Breast Cancer? Current Treatment Options for Advanced Breast Cancer Myths vs.
More informationWell documented, but incompletely understood, disparities are
188 Use of the National Cancer Data Base to Develop Clinical Trials Accrual Targets that Are Appropriate for Minority Ethnicity Patients A Report from the College of Surgeons Oncology Group (ACOSOG) Special
More informationLearning Objectives. ! At the end of the presentation,students will be able to:
Learning Objectives! At the end of the presentation,students will be able to: Define Breast Cancer Identify the controllable and uncontrollable risk factors of breast cancer Recognize the 4 stages of breast
More informationBSO, HRT, and ERT. No relevant financial disclosures
BSO, HRT, and ERT Jubilee Brown, MD Professor & Associate Director, Gynecologic Oncology Levine Cancer Institute at the Carolinas HealthCare System Charlotte, North Carolina No relevant financial disclosures
More informationRepairing the Disconnect: Optimizing Cancer Care Delivery in an Emerging Health Care System. Tracy A Battaglia MD MPH March 20, 2013
Repairing the Disconnect: Optimizing Cancer Care Delivery in an Emerging Health Care System Tracy A Battaglia MD MPH March 20, 2013 Aims/Objectives Describe the Disconnect : disparities in cancer care
More informationBLACK-WHITE DIFFERENCES IN SURVIVAL FROM LATE-STAGE PROSTATE CANCER
BLACK-WHITE DIFFERENCES IN SURVIVAL FROM LATE-STAGE PROSTATE CANCER Objective: To examine differences between African Americans (Blacks) and non-hispanic Whites in risk of death after diagnosis of laterstage
More informationTriple Negative Breast Cancer
Triple Negative Breast Cancer Prof. Dr. Pornchai O-charoenrat Division of Head-Neck & Breast Surgery Department of Surgery Faculty of Medicine Siriraj Hospital Breast Cancer Classification Traditional
More informationQuantitative Data: Measuring Breast Cancer Impact in Local Communities
Quantitative Data: Measuring Breast Cancer Impact in Local Communities Quantitative Data Report Introduction The purpose of the quantitative data report for the Southwest Florida Affiliate of Susan G.
More informationSurvival Difference between Non-Hispanic Black and Non-Hispanic White Women with Localized Breast Cancer: The Impact of Guideline-Concordant Therapy
o r i g i n a l c o m m u n i c a t i o n Survival Difference between Non-Hispanic Black and Non-Hispanic White Women with Localized Breast Cancer: The Impact of Guideline-Concordant Therapy Xiaocheng
More informationComparison of Triple Negative Breast Cancer between Asian and Western Data Sets
2010 IEEE International Conference on Bioinformatics and Biomedicine Workshops Comparison of Triple Negative Breast Cancer between Asian and Western Data Sets Lee H. Chen Bioinformatics and Biostatistics
More informationFactors Affecting Treatment Choice in HER2 Positive Metastatic Breast Cancer
Factors Affecting Treatment Choice in HER2 Positive Metastatic Breast Cancer A THESIS SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Eva Gallagher IN PARTIAL FULFILLMENT
More information8/8/2011. PONDERing the Need to TAILOR Adjuvant Chemotherapy in ER+ Node Positive Breast Cancer. Overview
Overview PONDERing the Need to TAILOR Adjuvant in ER+ Node Positive Breast Cancer Jennifer K. Litton, M.D. Assistant Professor The University of Texas M. D. Anderson Cancer Center Using multigene assay
More informationCDRI Cancer Disparities Geocoding Project. November 29, 2006 Chris Johnson, CDRI
CDRI Cancer Disparities Geocoding Project November 29, 2006 Chris Johnson, CDRI cjohnson@teamiha.org CDRI Cancer Disparities Geocoding Project Purpose: To describe and understand variations in cancer incidence,
More informationThyroid Cancer in New Mexico
Thyroid Cancer in New Mexico Time Trends and Surgical Treatment Preferences Ihsan Mahdi MD MPH Introduction The incidence of thyroid cancer incidence is increasing more rapidly than any other malignancy
More informationDisclosure. Objectives 03/19/2019. Current Issues in Management of DCIS Radiation Oncology Considerations
Current Issues in Management of DCIS Radiation Oncology Considerations Fariba Asrari, M.D. Director. Johns Hopkins Breast Center at Green Spring Station Department of Radiation Oncology & Molecular Sciences
More information